Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ·Healthcare·Biotechnology
$29.49
+0.75%
Mkt Cap $3.36B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $142.74M | $152.50M | +6.84% | $0.42 | $0.68 | +61.90% | — | — |
| Q4 2025 Nov 5, 2025 | $142.75M | $148.39M | +3.95% | $0.51 | $0.68 | +33.33% | — | — |
| Q3 2025 Aug 6, 2025 | $140.44M | $146.56M | +4.36% | $0.58 | $0.68 | +17.24% | — | — |
| Q2 2025 May 7, 2025 | $131.13M | $141.42M | +7.85% | $0.53 | $0.68 | +28.30% | — | — |
| Q1 2025 Feb 26, 2025 | $134.20M | $141.82M | +5.68% | $0.32 | $0.70 | +118.75% | — | — |
| Q4 2024 Nov 6, 2024 | $134.12M | $128.69M | -4.05% | $0.49 | $0.57 | +16.33% | — | — |
| Q3 2024 Aug 7, 2024 | $111.87M | $122.71M | +9.69% | $0.42 | $0.56 | +33.33% | — | — |
| Q2 2024 May 8, 2024 | $111.96M | $98.51M | -12.01% | $0.34 | $0.38 | +11.76% | — | — |
| Q1 2024 Feb 28, 2024 | $110.57M | $110.57M | +0.00% | $0.48 | $0.53 | +10.42% | — | — |
| Q4 2023 Nov 8, 2023 | $105.75M | $102.69M | -2.90% | -$0.24 | -$0.24 | +0.00% | — | — |
| Q3 2023 Aug 9, 2023 | $97.65M | $99.58M | +1.98% | $0.25 | $0.33 | +32.00% | — | — |
| Q2 2023 May 10, 2023 | $92.73M | $85.37M | -7.94% | $0.32 | $0.26 | -18.75% | — | — |
| Q1 2023 Mar 15, 2023 | $58.09M | $60.76M | +4.59% | $0.21 | $0.22 | +4.76% | — | — |
| Q4 2022 Nov 9, 2022 | $53.69M | $57.24M | +6.61% | $0.19 | $0.20 | +5.26% | — | — |
| Q3 2022 Aug 9, 2022 | $49.21M | $53.11M | +7.92% | $0.17 | $0.20 | +17.65% | — | — |
| Q2 2022 May 10, 2022 | $42.75M | $43.09M | +0.78% | $0.14 | $0.12 | -14.29% | — | — |
| Q1 2022 Mar 16, 2022 | $38.18M | $38.31M | +0.33% | $0.12 | $0.09 | -25.00% | — | — |
| Q4 2021 Nov 9, 2021 | $34.59M | $35.95M | +3.94% | $0.10 | $0.10 | +0.00% | — | — |
| Q3 2021 Aug 9, 2021 | $33.75M | $36.37M | +7.74% | $0.09 | $0.16 | +77.78% | — | — |
| Q2 2021 May 10, 2021 | $36.92M | $30.20M | -18.18% | $0.09 | $0.11 | +22.22% | — | — |